“Declare the past, diagnose the present, foretell the future.”

– Hippocrates

Atopic dermatitis is a chronic disease with a genetic predisposition characterized by a rash, intense skin itching and suppressed immune functions of the skin.

It usually begins in childhood and people who have atopic dermatitis have hypersensitive skin, as well as a reduced threshold of irritation. As a result, atopic dermatitis is often associated with asthma, allergies, and chronic dermatitis.

Atopic dermatitis

Epidemiology, Etiology and Diagnosis

Atopic dermatitis occurs in 3-15% of the total population:

  • Children 5-20%
  • Adults 2-10%

The exact cause of the eczema is not completely clear: genetic predisposition – the phyllagrin gene, skin barrier disorder, “Hygiene hypothesis” or intestinal dysbiosis, which occurs in 80-90% of children with atopic dermatitis.

Diagnosis is based on blood tests and skin allergy testing for inhaled or nutritional antigens.


Mostly symptomatic:

  • topical steroids or calcineurin inhibitors (Elidel)
  • antihistamines
  • antibiotics for suspected skin bacterial infection
  • and/or oral corticosteroids – eczema returns after discontinuation

They are effective but can also cause serious side effects if taken over a long period of time.

Salapon® provides a new therapeutic option.

The use of Salapon® together with standard therapy of atopic dermatitis improves the effectiveness of therapy in the form of:

  • Clinical improvement in 56.76% of patients

  • Average SCORAD index decrease by 71.94%
  • Itching disappears during the day and night in 50% of patients

  • Itching disappears during the day and night in 50% of patients

Salapon® tablets lead to a visible improvement in the quality of the skin and the general condition of the body if they are used for 21 days in the treatment of detoxification of the body.

Back to Home